These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3422560)

  • 21. Cellular transport of anthracyclines by passive diffusion. Implications for drug resistance.
    Siegfried JM; Burke TG; Tritton TR
    Biochem Pharmacol; 1985 Mar; 34(5):593-8. PubMed ID: 3856430
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction of nucleosomes with anthracycline antibiotics: relevance to anticancer activity.
    Palumbo M; Cera C; Marciani-Magno S; Palù G
    Biochem Pharmacol; 1988 May; 37(9):1871-2. PubMed ID: 3163927
    [No Abstract]   [Full Text] [Related]  

  • 23. A new antitumor antibiotic, carminomycin (NSC-180024).
    Gause GF; Brazhnikova MG; Shorin VA
    Cancer Chemother Rep; 1974; 58(2):255-6. PubMed ID: 4830498
    [No Abstract]   [Full Text] [Related]  

  • 24. Mechanistic aspects of DNA damage by morpholinyl and cyanomorpholinyl anthracyclines.
    Westendorf J; Aydin M; Groth G; Weller O; Marquardt H
    Cancer Res; 1989 Oct; 49(19):5262-6. PubMed ID: 2766295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical parameters of growth inhibition of human leukemia cells by antitumor anthracycline agents.
    Schwartz HS; Kanter PM
    Cancer Treat Rep; 1979 May; 63(5):821-5. PubMed ID: 287555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of anthracycline derivatives with DNA: a fluorescence study.
    Valentini L; Nicolella V; Vannini E; Menozzi M; Penco S; Arcamone F
    Farmaco Sci; 1985 Jun; 40(6):377-90. PubMed ID: 3861331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anthracycline antineoplastic drugs.
    Young RC; Ozols RF; Myers CE
    N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
    [No Abstract]   [Full Text] [Related]  

  • 28. Redox activities of antitumor anthracyclines determined by microsomal oxygen consumption and assays for superoxide anion and hydroxyl radical generation.
    Peters JH; Gordon GR; Kashiwase D; Lown JW; Yen SF; Plambeck JA
    Biochem Pharmacol; 1986 Apr; 35(8):1309-23. PubMed ID: 3008758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
    Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of tunicamycin on anthracycline resistance in P388 murine leukemia cells.
    Chou TH; Kessel D
    Biochem Pharmacol; 1981 Nov; 30(22):3134-6. PubMed ID: 6950722
    [No Abstract]   [Full Text] [Related]  

  • 31. Combination chemotherapy with a new anthracycline glycoside, aclacinomycin-A, and active drugs for malignant lymphomas in P388 mouse leukemia system.
    Fujimoto S; Inagaki J; Horikoshi N; Ogawa M
    Gan; 1979 Aug; 70(4):411-20. PubMed ID: 92432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Markedly reduced levels of anthracycline-induced DNA strand breaks in resistant P388 leukemia cells and isolated nuclei.
    Capranico G; Riva A; Tinelli S; Dasdia T; Zunino F
    Cancer Res; 1987 Jul; 47(14):3752-6. PubMed ID: 3474061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental study of the antitumor anthracycline antibiotic aclarubicin (aclacinomycin A)].
    Egorov LV; Terent'eva TG; Rudneva NA; Egorenko GG; Ivanitskaia LP
    Antibiot Med Biotekhnol; 1985 Dec; 30(12):918-27. PubMed ID: 3866512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbial conversion of epsilon-pyrromycinone to 1-hydroxy-11-deoxycarminomycin II.
    Nakagawa M; Hayakawa Y; Imamura K; Seto H; Otake N
    J Antibiot (Tokyo); 1985 Jun; 38(6):821-2. PubMed ID: 4019326
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytotoxic and mutagenic in vitro effect of 7-O-epoxyalkyl derivatives of daunomycinone. Part IX.
    Sturdíková M; Fusková A; Prikrylová V; Podojil M; Fuska J
    Neoplasma; 1986; 33(3):297-305. PubMed ID: 2426609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strong binding of ditrisarubicin B to DNA.
    Kunimoto S; Takahashi Y; Uchida T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1988 May; 41(5):655-9. PubMed ID: 3384751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of antineoplastic antibiotics and DNA.
    Gause GF; Dudnik YV
    Antibiot Chemother (1971); 1980; 28():102-8. PubMed ID: 6158286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental evaluation of anthracycline analogs.
    Casazza AM
    Cancer Treat Rep; 1979 May; 63(5):835-44. PubMed ID: 455325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
    Kessel D; Wilberding C
    Cancer Res; 1985 Apr; 45(4):1687-91. PubMed ID: 3919944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between the intracellular accumulation of anthracyclines and effectiveness in vitro and in vivo.
    Tapiero H; Munck JN; Fourcade A
    Drugs Exp Clin Res; 1986; 12(1-3):257-64. PubMed ID: 3460752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.